
Stress and cortisol: what the wellness industry gets wrong
Cortisol is having a marketing moment. The physiology is more ordinary — and the tests are less revealing — than the ads suggest.
Reporting on guideline revisions, drug approvals, safety warnings and newly published studies affecting women's care, each traced to the source document.

Cortisol is having a marketing moment. The physiology is more ordinary — and the tests are less revealing — than the ads suggest.

A plain-language checklist for reading past the headline, spotting preliminary research, and deciding whether a health story is worth passing on.

Patients can now swab themselves for cervical cancer screening in a clinic, and one at-home kit is FDA-approved. Here is what each approval covers, what the evidence shows, and where national guidance still stands.

More than half of states now let Medicaid pay for a doula, but reporting on the ground shows low reimbursement and looming federal cuts are keeping the benefit out of reach for many who qualify.

Opill's OTC availability since 2024 changed access rules, but coverage and pharmacists' standing-order rules vary by state.

Viatris announced approval on July 29, 2026, adding a lower estrogen-dose option to the small US patch market.